8th International Symposium on Coagulation in Liver Disease

Sept 27th-28th 2019, Groningen, The Netherlands

 

Organisers : Ton Lisman (Groningen NL), Robert Porte (Groningen, NL), Nicolas Intagliata (Charlottesville, VA, USA), Stephen Caldwell (Charlottesville, VA, USA)

Curriculum advisors: Juan-Carlos Garcia-Pagan (Barcelona, Spain), Patrick Northup (Charlottesville, VA, USA), Craig Jenne (Calgary, Canada), James Luyendyk (East Lansing, MI, USA)

 

Friday, Sept 27th

 

9:00 – 9:15      Welcome – Ton Lisman (Groningen NL) & Stephen Caldwell (Charlottesville, VA, USA)

9:15 – 9:50      Keynote lecture 1 – Translational research on CILD: knowns and unknowns – Ton Lisman (Groningen NL)

 

Session 1 – Magnitude of the clinical problems:

9:50 – 10:15    Incidence of procedural bleeding – Jonel Trebicka (Bonn, Germany)

10:15 – 10:40  Incidence bleeding and thrombosis in ALF – Todd Stravitz (Richmond, VA, USA)

 

Coffee

 

11:05 – 11:30  Incidence bleeding and thrombosis in acutely ill patients – William Bernal (London, UK)

11:30 – 11:55  Prophylactic blood product use in liver patients – Simon Stanworth (Oxford, UK)

 

Lunch

 

13:00 – 14:00 Abstracts and trainees session

 

Session 2 – Management of bleeding and thrombosis

14:00 – 14:35  Keynote lecture 2 – TPO receptor agonists – what do they deliver? – Norah Terrault (San Francisco, CA, USA)

14:35 – 15:00  Thromboprophylaxis – is it needed? Is it effective? – Patrick Northup (Charlottesville, VA, USA)

 

Teabreak

 

15:45 – 16:05  Modeling of efficacy of pro- and anticoagulants – Ton Lisman (Groningen, NL)

16:05 – 16:30  Cirroxaban study – Juan-Carlos Garcia-Pagan (Barcelona, Spain)

16:30 – 16:55  Edoxaban study – Sarah Bos (Groningen, NL)

 

Posters

 

 

Saturday, September 28th

 

Session 3 – Portal vein thrombosis:

9:00 – 9:35      Keynote lecture 3 – PVT – an overview – Nicolas Intagliata (Charlottesville, VA, USA)

9:35 – 10:00    Predictors of cirrhotic PVT – Fanny Turon (Barcelona, Spain)

10:00 – 10:25  HCV treatment – effects on coagulation and PVT risk – Paolo Simioni (Padua, Italy)

 

Coffee

 

10:40 – 11:05  Transient portal vein thrombosis – Dominique Valla (Clichy, France)

11:05 – 11:30  Recurrent portal vein thrombosis – Francesco Violi (Roma, Italy)

 

11:30 – 11:55  Invasive therapies for portal vein thrombosis – Ziv Haskel (Charlottesville, VA, USA)

11:55 – 12:20  A surgeon’s perspective on cirrhotic portal vein thrombosis – Nigel Heaton (London, UK)

 

Lunch

 

Session 4 – New players and mechanisms

13:30 – 14:05  Keynote lecture 4 – TGA, TEG, ROTEM, Sonorheometry – what do they deliver? – Neeral Shah (Charlottesville, VA, USA)

14:05 – 14:30  Thrombin and fibrin in progression of fatty liver disease – Matthew Flick (Cincinnati, OH, USA)

14:30 – 14:55  The endothelium in cirrhotic thrombosis – Virginina Hernández-Gea (Barcelona, Spain)

14:55 – 15:20  Hemostasis and liver regeneration – experimental perspective – James Luyendyk (East Lansing, MI, USA)

 

Teabreak

 

15:45 – 16:10  Hemostasis and liver regeneration – human perspective – Patrick Starlinger (Vienna, Austria)

16:10 – 16:35  NETs and coagulation – Fien von Meijenfeldt (Groningen, NL)

16:35 – 17:00  Anticoagulation and the risk of fibrin formation during ex-situ machine perfusion of donor livers for transplantation – Robert Porte (Groningen, NL)